An Act Increasing The Bond Authorization For The Connecticut Bioscience Innovation Fund.
Summary
SB 124 would amend section 32-41dd of the Connecticut General Statutes to increase the bond authorization for the Connecticut Bioscience Innovation Fund by $25 million. The bill is narrowly focused on expanding the amount of state-backed bonding available for this existing fund, which is intended to support bioscience innovation in Connecticut.
In practical terms, the bill would authorize additional bonding capacity for the state to invest in bioscience-related economic development, research, and innovation activities. It does not create a new program or change eligibility rules; rather, it increases the financing ceiling for an existing fund used to support the bioscience sector.
Impact
The bill would directly amend state bonding law by raising the statutory bond authorization for the Connecticut Bioscience Innovation Fund by $25 million. This would affect state fiscal policy and the availability of capital for bioscience initiatives, potentially benefiting companies, researchers, startups, and institutions involved in life sciences and biotechnology. Because the bill is limited to bond authorization, its legal effect is to expand the state’s capacity to issue bonds for this purpose under section 32-41dd.
Sentiment
There is no recorded committee testimony or vote history in the provided materials, so no formal public sentiment can be measured from the record here. Based on the bill text and statement of purpose, the measure appears supportive of bioscience investment and economic development, with an emphasis on increasing funding rather than imposing new restrictions or obligations.
Contention
No specific points of contention are documented in the provided transcripts or voting history. Potential areas of debate, if raised, would likely concern the size of the bond increase, the use of state debt for sector-specific economic development, and whether the bioscience industry should receive additional public financing relative to other priorities. However, none of those concerns are reflected in the available record.